Protein-losing Enteropathy Complicated with Primary Intestinal Follicular Lymphoma.
primary intestinal follicular lymphoma
protein-losing enteropathy
rituximab
Journal
Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241
Informations de publication
Date de publication:
01 Jul 2022
01 Jul 2022
Historique:
pubmed:
30
11
2021
medline:
7
7
2022
entrez:
29
11
2021
Statut:
ppublish
Résumé
Protein-losing enteropathy (PLE) is a rare syndrome characterized by hypoproteinemia due to gastrointestinal (GI) protein loss. Primary intestinal follicular lymphoma (PIFL), a specific variant of follicular lymphoma with essential only GI involvement, has not been reported as an etiology of PLE. We herein report a case of PLE complicated with PIFL that was successfully treated with rituximab, resulting in rapid improvement of PLE and a complete response of PIFL. Macroscopic findings of ulcerative lesions with diffuse involvement, which were precisely described by capsule and double-balloon enteroscopy at the diagnosis, also improved following the treatment. This case provides a clue suggesting factors that promote PLE in PIFL.
Identifiants
pubmed: 34840227
doi: 10.2169/internalmedicine.8261-21
pmc: PMC9334233
doi:
Substances chimiques
Rituximab
4F4X42SYQ6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2051-2055Références
J Gastroenterol. 2010 Apr;45(4):370-88
pubmed: 20084529
Am J Gastroenterol. 2010 Jan;105(1):43-9; quiz 50
pubmed: 19789526
Cancer Sci. 2011 Aug;102(8):1532-6
pubmed: 21561531
Ann Oncol. 1994 May;5(5):397-400
pubmed: 8075046
Gastrointest Endosc. 2008 Apr;67(4):763-5
pubmed: 18207144
Intern Med. 2008;47(24):2171-3
pubmed: 19075545
J Clin Oncol. 2011 Apr 10;29(11):1445-51
pubmed: 21383289
Am J Clin Oncol. 2003 Aug;26(4):408-10
pubmed: 12902896
BMJ Case Rep. 2020 Dec 13;13(12):
pubmed: 33318279
Am J Clin Oncol. 2009 Apr;32(2):222-3
pubmed: 19346818
Endoscopy. 2009 Feb;41(2):175-8
pubmed: 19214900